These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25780)

  • 1. Successful therapy of viral leukemia by transplantation of histocompatibly unmatched marrow.
    Meredith RF; Okunewick JP; Kuhnert PM; Brozovich BJ; Weaver EV
    Exp Hematol; 1978 Mar; 6(3):273-82. PubMed ID: 25780
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rauscher leukemia as a model for studies of marrow transplantation therapy: results using syngeneic, allogeneic and hybrid donors.
    Okunewick JP; Meredith RF; Brozovich BJ; Seeman PR; Schieb AL
    Int J Cancer; 1979 Oct; 24(4):438-44. PubMed ID: 43293
    [No Abstract]   [Full Text] [Related]  

  • 4. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Flinton LJ; Simon JD; Kelley RJ; Albala MM
    Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective donor T-cell depletion on the graft-versus-leukemia reaction in allogeneic marrow transplantation.
    OKunewick J; Kociban D; Machen L; Buffo M
    Transplant Proc; 1992 Dec; 24(6):2998-9. PubMed ID: 1361270
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility influence in allogeneic marrow transplantation therapy of murine viral leukemia. I.--Studies of the relative influence of major versus minor histocompatibility determinants.
    Meredith RF; Okunewick JP; Raikow RB; Brozovich BJ; Seeman PR; Magliere KC
    Biomedicine; 1981 Feb; 34(1):11-7. PubMed ID: 7013840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD4 and CD8 T cells in the graft-versus-leukemia response in Rauscher murine leukemia.
    OKunewick JP; Kociban DL; Machen LL; Buffo MJ
    Bone Marrow Transplant; 1991 Dec; 8(6):445-52. PubMed ID: 1686416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase in number of splenic transplantable colony-forming units in the SJL-J mice after infection with Rauscher leukemia virus.
    O'Kunewick JP; Phillips EL; Erhard P
    J Natl Cancer Inst; 1972 Oct; 49(4):1101-6. PubMed ID: 4404347
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
    Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation.
    Storb R; Santos GW
    Transplant Proc; 1979 Mar; 11(1):1163-6. PubMed ID: 36699
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemic transformation of donor spleen cells following their transplantation into superlethally irradiated mice with pre-existing viral leukemia.
    Kuhnert PM; OKunewick JP; Erhard
    Exp Hematol; 1974; 2(6):328-35. PubMed ID: 4156671
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the radioprotective capacity of spleen cells transplanted from mice with Rauscher viral leukemia.
    Okunewick JP; Erhard P
    Radiat Res; 1973 Feb; 53(2):241-7. PubMed ID: 4144413
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunobiology of bone marrow transplantation.
    Dicke KA; Lotzova E; Spitzer G; McCredie KB
    Semin Hematol; 1978 Jul; 15(3):263-82. PubMed ID: 27865
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study of the antileukemic effect of Endoxan in combination with bone marrow cell and spleen cell transplantation].
    Bergol'ts VM; Sukhin GM
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):36-9. PubMed ID: 4900638
    [No Abstract]   [Full Text] [Related]  

  • 19. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time pattern of antileukemic effect of graft-versus-host reaction in mice.
    Boranić M
    Transplant Proc; 1971 Mar; 3(1):394-6. PubMed ID: 4398494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.